Literature DB >> 11841938

Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors.

Paul A Clemons1, Brian G Gladstone, Abhinav Seth, Elizabeth D Chao, Michael A Foley, Stuart L Schreiber.   

Abstract

We used olefin metathesis to synthesize C40 derivatives of FK506 and measured their ability, when complexed to FKBP12, to inhibit calcineurin's phosphatase activity. We identified modular dimerization domains (CABs) containing segments of the calcineurin A and B polypeptides. These CABs respond to FK506 both when overexpressed in mammalian cells and in yeast or mammalian three-hybrid assays. Using chemical genetic selection, we identified compensatory mutant CABs that respond to a calcineurin-resistant FK506 derivative at concentrations well below the response threshold for CABs containing only wild-type calcineurin sequence. These reagents provide a small molecule-protein combination orthogonal to existing dimerizer systems and may be used with existing systems to increase the complexity of induced-proximity experiments. This new use of the "bump-hole" strategy protects target cells from complications arising from the inhibition of endogenous calcineurin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841938     DOI: 10.1016/s1074-5521(02)00085-6

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  10 in total

1.  Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.

Authors:  Yan Zhang; Marie-Hélène Larraufie; Leila Musavi; Hemanth Akkiraju; Lewis M Brown; Brent R Stockwell
Journal:  Biochemistry       Date:  2018-02-06       Impact factor: 3.162

Review 2.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

3.  Activation of BMP Signaling by FKBP12 Ligands Synergizes with Inhibition of CXCR4 to Accelerate Wound Healing.

Authors:  Brandon J Peiffer; Le Qi; Ali R Ahmadi; Yuefan Wang; Zufeng Guo; Hanjing Peng; Zhaoli Sun; Jun O Liu
Journal:  Cell Chem Biol       Date:  2019-02-28       Impact factor: 8.116

4.  Two-drug trick to target the brain blocks toxicity in the body.

Authors:  Matthias P Wymann; Chiara Borsari
Journal:  Nature       Date:  2022-09       Impact factor: 69.504

5.  Drug Modulators of B Cell Signaling Pathways and Epstein-Barr Virus Lytic Activation.

Authors:  John G Kosowicz; Jaeyeun Lee; Brandon Peiffer; Zufeng Guo; Jianmeng Chen; Gangling Liao; S Diane Hayward; Jun O Liu; Richard F Ambinder
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

6.  Selective Targeting of Cells via Bispecific Molecules That Exploit Coexpression of Two Intracellular Proteins.

Authors:  Bryan M Dunyak; Robert L Nakamura; Alan D Frankel; Jason E Gestwicki
Journal:  ACS Chem Biol       Date:  2015-09-02       Impact factor: 5.100

7.  Synthesis of orthogonally reactive FK506 derivatives via olefin cross metathesis.

Authors:  Paul S Marinec; Christopher G Evans; Garrett S Gibbons; Malloree A Tarnowski; Daniel L Overbeek; Jason E Gestwicki
Journal:  Bioorg Med Chem       Date:  2009-07-18       Impact factor: 3.641

8.  Activation of NF-κB signalling by fusicoccin-induced dimerization.

Authors:  Malgorzata Skwarczynska; Manuela Molzan; Christian Ottmann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-26       Impact factor: 11.205

9.  Self-Reporting Chemically Induced Protein Proximity System Based on a Malachite Green Derivative and the L5** Fluorogen Activating Protein.

Authors:  Guihua Zeng; Yi Wang; Marcel P Bruchez; Fu-Sen Liang
Journal:  Bioconjug Chem       Date:  2018-08-20       Impact factor: 4.774

10.  Brain-restricted mTOR inhibition with binary pharmacology.

Authors:  Ziyang Zhang; Qiwen Fan; Xujun Luo; Kevin Lou; William A Weiss; Kevan M Shokat
Journal:  Nature       Date:  2022-09-14       Impact factor: 69.504

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.